Small-scale single-use platforms can be scaled directly to commercial manufacturing, significantly shortening the timeline to market commercialization. Around 90 percent of biomanufacturing facilities utilize single-use technologies in clinical manufacturing1 and many have begun to explore its potential for commercial manufacturing. The benefits of single-use technology have been widely discussed. They include the potential for a…